OTC Healthcare in Slovenia
Euromonitor International's OTC Healthcare in Slovenia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 93 | Publication date: Feb 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Ageing Population and Marketing Drive OTC Healthcare Sales
Life expectancy in Slovenia is increasing. Additionally, the Slovenian population is the most rapidly ageing in the EU. Boosted by aggressive marketing from the leading players, total OTC healthcare sales grew by almost 13% in 2008. Unit price rises recorded across all categories of OTC healthcare contributed to strong value sales growth, however this was not as strong as the increases in consumption, which were accelerated by successful marketing.
Marketing is Crucial
During 2008, leading players such as Lek Pharmaceuticals dd, Bayer Pharma doo and Krka dd saw significant potential for further growth within sales of OTC remedies to be generated by aggressive marketing. Thus all three companies invested large amounts of money in key advertising campaigns to support their leading brands, thereby achieving strong growth rates, especially for cough, cold and allergy (hay fever) remedies. Other companies went even further and reduced the number of units per pack yet maintained the same retail selling price as in 2007; surprisingly, sales almost doubled despite the fact that unit prices were now significantly higher. In general, marketing tools boosted value sales in 2008, filling the gap left by the absence of any new product or packaging innovations.
Domestic Pharmaceutical Companies Continue to Lead
Domestic manufacturers maintained their leading positions within OTC healthcare during 2008, Lek Pharmaceuticals dd as number one and Krka dd as number two. Both companies invested in marketing support for their leading brands. Lek Pharmaceuticals’s Lekadol brand is not only the overall leader within OTC healthcare but also received a nomination for the most trusted brand of 2008 in two categories – analgesics and cough, cold and allergy (hay fever) remedies – by the Mediana institute for media research.
Chemists/Pharmacies is Almost the Only Distribution Channel
Chemists/pharmacies accounted for 94% of total value sales in 2008, since the majority of products are still available only in such outlets. Loud rumours in 2006 and 2007 concerning some OTC healthcare products becoming available through specialist stores or even parapharmacies/drugstores died down in 2008. Thus it appears that Slovenians will continue to purchase OTC healthcare products in chemists/pharmacies over the forecast period.
Potential Remains for Further Growth
Slovenian demographic trends would seem to favour the growth of OTC healthcare, however this will not be enough on its own to maintain constant value sales at positive growth rates. Marketing support and new product launches will also be necessary for the further development of OTC healthcare sales. However, industry sources point out that expected high levels of inflation between 2008-2013 could also be a principal generator of value sales growth.
Table of contents
OTC HEALTHCARE IN SLOVENIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Ageing Population and Marketing Drive OTC Healthcare Sales
Marketing is Crucial
Domestic Pharmaceutical Companies Continue to Lead
Chemists/Pharmacies is Almost the Only Distribution Channel
Potential Remains for Further Growth
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
ANALGESICS IN SLOVENIA
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SLOVENIA
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN SLOVENIA
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN SLOVENIA
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Medicated Skin Care Company Shares by Value 2004-2008
Table 41 Medicated Skin Care Brand Shares by Value 2005-2008
Table 42 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN SLOVENIA
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 47 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 48 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 49 Vitamins Brand Shares by Value 2005-2008
Table 50 Dietary Supplements Brand Shares by Value 2005-2008
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN SLOVENIA
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Indicators
Table 53 Number of Smokers by Gender 2003-2008
Sector Indicators
Table 54 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 55 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 56 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 57 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 59 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN SLOVENIA
Trends
Sector Data
Table 60 Sales of Eye Care by Subsector: Value 2003-2008
Table 61 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 62 Eye Care Company Shares by Value 2004-2008
Table 63 Eye Care Brand Shares by Value 2005-2008
Table 64 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 65 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS IN SLOVENIA
Trends
Sector Data
Table 66 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 67 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 68 Wound Treatments Company Shares by Value 2004-2008
Table 69 Wound Treatments Brand Shares by Value 2005-2008
Table 70 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 71 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE IN SLOVENIA
Trends
ADULT MOUTH CARE IN SLOVENIA
Trends
Sector Data
Table 72 Sales of Adult Mouth Care: Value 2003-2008
Table 73 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 74 Adult Mouth Care Company Shares by Value 2004-2008
Table 75 Adult Mouth Care Brand Shares by Value 2005-2008
Table 76 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 77 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN SLOVENIA
Trends
Sector Data
Table 78 Sales of Calming and Sleeping Products: Value 2003-2008
Table 79 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 80 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 81 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 82 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 83 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION IN SLOVENIA
Trends
OTC OBESITY IN SLOVENIA
Trends
OTC TRIPTANS IN SLOVENIA
Trends
KRKA DD
Strategic Direction
Key Facts
Summary 2 Krka dd: Key Facts
Summary 3 Krka dd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Krka dd: Competitive Position 2008
LEK PHARMACEUTICALS DD
Strategic Direction
Key Facts
Summary 5 Lek Pharmaceuticals dd: Key Facts
Summary 6 Lek Pharmaceuticals dd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Lek Pharmaceuticals dd: Competitive Position 2008
MEDIS DOO
Strategic Direction
Key Facts
Summary 8 Medis doo: Key Facts
Summary 9 Medis doo: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Medis doo: Competitive Position 2008